Nektar Therapeutics (NKTR) — Cash Flow Quality Index
Nektar Therapeutics (NKTR) has a Cash Flow Quality Index of -6.36x as of December 2024. Operating cash flow of $-46.19 Million is below net income of $7.26 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Nektar Therapeutics (NKTR) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nektar Therapeutics Cash Flow Quality Index (2018–2018)
Historical Cash Flow Quality Index for Nektar Therapeutics across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Nektar Therapeutics's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Nektar Therapeutics (2018–2018)
Year-by-year earnings quality comparison for Nektar Therapeutics. For live market cap and the full company financial profile, see NKTR market cap overview.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 1.05x | $718.21 Million | $681.31 Million | — |